Literature DB >> 33136615

Translational models of cannabinoid vapor exposure in laboratory animals.

Catherine F Moore1, Jeffrey W Stiltner, Catherine M Davis, Elise M Weerts.   

Abstract

Cannabis is one of the most frequently used psychoactive substances in the world. The most common route of administration for cannabis and cannabinoid constituents such as Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is via smoking or vapor inhalation. Preclinical vapor models have been developed, although the vaporization devices and delivery methods vary widely across laboratories. This review examines the emerging field of preclinical vapor models with a focus on cannabinoid exposure in order to (1) summarize vapor exposure parameters and other methodological details across studies; (2) discuss the pharmacological and behavioral effects produced by exposure to vaporized cannabinoids; and (3) compare behavioral effects of cannabinoid vapor administration with those of other routes of administration. This review will serve as a guide for past and current vapor delivery methods in animals, synergize findings across studies, and propose future directions for this area of research.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 33136615      PMCID: PMC8079522          DOI: 10.1097/FBP.0000000000000592

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  194 in total

1.  Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood.

Authors:  Lauren C Kruse; Jessica K Cao; Katie Viray; Nephi Stella; Jeremy J Clark
Journal:  Neuropsychopharmacology       Date:  2019-04-10       Impact factor: 7.853

2.  Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

3.  Rats self-administer sufentanil in aerosol form.

Authors:  A B Jaffe; L G Sharpe; J H Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.

Authors:  Samantha Goodman; Elle Wadsworth; Cesar Leos-Toro; David Hammond
Journal:  Int J Drug Policy       Date:  2020-01-09

5.  Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.

Authors:  Marco Pistis; Luca Ferraro; Luigi Pira; Giovanna Flore; Sergio Tanganelli; Gian Luigi Gessa; Paola Devoto
Journal:  Brain Res       Date:  2002-09-06       Impact factor: 3.252

Review 6.  Cannabis use and obesity and young adults.

Authors:  Mohammad R Hayatbakhsh; Michael J O'Callaghan; Abdullah A Mamun; Gail M Williams; Alexandra Clavarino; Jake M Najman
Journal:  Am J Drug Alcohol Abuse       Date:  2010-10-12       Impact factor: 3.829

7.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

Authors:  M Navarro; E Hernández; R M Muñoz; I del Arco; M A Villanúa; M R Carrera; F Rodríguez de Fonseca
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

Review 8.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 9.  Tetrahydrocannabinol and endocannabinoids in feeding and appetite.

Authors:  Elliot M Berry; Raphael Mechoulam
Journal:  Pharmacol Ther       Date:  2002-08       Impact factor: 12.310

10.  Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.

Authors:  Jerzy P Szaflarski; Elizabeth Martina Bebin; Gary Cutter; Jennifer DeWolfe; Leon S Dure; Tyler E Gaston; Pongkiat Kankirawatana; Yuliang Liu; Rani Singh; David G Standaert; Ashley E Thomas; Lawrence W Ver Hoef
Journal:  Epilepsy Behav       Date:  2018-08-09       Impact factor: 2.937

View more
  4 in total

1.  Female rats self-administer heroin by vapor inhalation.

Authors:  Arnold Gutierrez; Jacques D Nguyen; Kevin M Creehan; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2020-10-24       Impact factor: 3.533

2.  Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex.

Authors:  Catherine F Moore; Catherine M Davis; Eric L Harvey; Michael A Taffe; Elise M Weerts
Journal:  Pharmacol Biochem Behav       Date:  2021-01-23       Impact factor: 3.533

3.  Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents.

Authors:  Bryan W Jenkins; Shoshana Buckhalter; Melissa L Perreault; Jibran Y Khokhar
Journal:  Schizophr Bull Open       Date:  2021-11-20

4.  Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats.

Authors:  Jenny L Wiley; Shanequa I Taylor; Julie A Marusich
Journal:  Drug Alcohol Depend       Date:  2021-06-23       Impact factor: 4.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.